NIMG-52. UNCERTAINTY QUANTIFICATION IN RADIOMICS. (11th November 2019)

• Record Type: Journal Article
• Authors: Wang, Lujia; Yoon, Hyunsoo; Hawkins-Daarud, Andrea; Singleton, Kyle; Clark-Swanson, Kamala; Smith, Kris; Nakaji, Peter; Eschbacher, Jenny; Baxter, Leslie; Gonzalez, Ashlyn; Nespodzany, Ashley; Bendok, Bernard; Patra, Devi; De Leon, Gustavo; Zimmerman, Richard; Porter, Alyx; Krishna, Chandan; Salomao, Marcela; Hoxworth, Joseph; Zhou, Yuxiang; Mrugala, Maciej; Tran, Nhan; Wu, Teresa; Swanson, Kristin; Li, Jing; Hu, Leland
• Is Part Of: Neuro-oncology. Volume 21(2019)Supplement 6
• Page Start: vi172
• Page End: vi173
• Publication Date: 2019-11-11
• Subjects: Brain Neoplasms -- Periodicals; Brain -- Tumors -- Periodicals; Brain -- Cancer -- Periodicals; Nervous system -- Cancer -- Periodicals; 616.99481
• DOI: 10.1093/neuonc/noz175.721
• Languages: English
• ISSNs: 1522-8517

Abstract

Abstract: INTRODUCTION: The quantification of intratumoral heterogeneity – through radiomics-based approaches - can help resolve the regionally distinct genetic drug targets that may co-exist within a single Glioblastoma (GBM) tumor. While this offers potential diagnostic value under the paradigm of individualized oncology, clinical decision-making must also consider the degree of uncertainty associated with each model. In this study, we evaluate the performance of a novel machine-learning (ML) algorithm, called Gaussian Process (GP) modeling, that can quantify the impact of multiple sources of uncertainty in ML model development and prediction accuracy, including variabilities in the copy number measurement, radiomics features, training sample characteristics, and training sample size. METHOD: We collected 95 image-localized biopsies from 25 primary GBM patients. We coregistered stereotactic locations with preoperative multi-parametric MRI features (conventional MRI, DSC perfusion, Diffusion Tensor Imaging) to generate spatially matched pairs of MRI and copy number variants (CNV) for for each biopsy. We developed a Gaussian Process (GP) model to predict CNV for Epidermal Growth Factor Receptor (EGFR) based on MRI radiomic features in each patient. We used leave-one-patient-out cross validation to quantify prediction accuracy and model uncertainty. Spatial prediction and uncertainty (p-value) maps were overlaid to help visualize regional genetic variation of EGFR and uncertainty of the radiomic predictions. RESULT: The initial GP radiomics model for EGFR amplification (CNV > 3.5) produced a sensitivity of 0.8 and specificity of 0.8. Samples/regions associated with high uncertainty (p-value >0.05) correlated with either 1) extrapolation of radiomic features from the training set-defined feature space or 2) insufficient training samples in the feature space. CONCLUSION: We present a ML-based model that quantifies spatial genetic heterogeneity in GBM, while also estimating model uncertainties that result from multi-source data variabilities. This approach lays the groundwork for prospective clinical integration of modeling-based diagnostic approaches in the paradigm of individualized medicine.